-
Mashup Score: 0Is Adding an AI Readout to Mammography Worth It? - 4 month(s) ago
Women would have to pay out-of-pocket, as reimbursement is a long way off
Source: www.medpagetoday.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3AI spots signs of rheumatic heart disease in echocardiograms as well as cardiologists - 4 month(s) ago
Researchers think this represents a potential breakthrough for low- and middle-income countries where access to high-quality imaging evaluations is still limited.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4Hybrid coronary revascularization vs. CABG for multivessel CAD: New meta-analysis tracks long-term outcomes - 4 month(s) ago
A hybrid approach may increase the risk of certain adverse events, according to a new meta-analysis focused on long-term outcomes.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Hybrid coronary revascularization vs. CABG for multivessel CAD: New meta-analysis tracks long-term outcomes - 5 month(s) ago
A hybrid approach may increase the risk of certain adverse events, according to a new meta-analysis focused on long-term outcomes.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Cardiawave’s non-invasive ultrasound therapy impresses cardiologists early on—could it be an alternative to SAVR, TAVR? - 5 month(s) ago
While TAVR and SAVR are reliable treatments for calcific aortic stenosis, some patients are not considered for those procedures due to severe comorbidities or a limited life expectancy. This is where the investigational Valvosoft device from Cardiawave enters the equation.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Daily marijuana use increases heart failure risk by 34% - 6 month(s) ago
“Marijuana use isn’t without its health concerns, and our study provides more data linking its use to cardiovascular conditions,” one researcher said.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4
The system, designed for patients with uncontrolled hypertension who are unresponsive to medication, uses ultrasound ablation to target nerves in the renal arteries, increasing blood flow. This approval comes just months after an FDA advisory panel voted in favor of the system.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
The new-look algorithm, trained and validated with data from more than 25,000 patients, scans a patient’s electronic health record and identifies signs of trouble.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
The new-look algorithm, trained and validated with data from more than 25,000 patients, scans a patient’s electronic health record and identifies signs of trouble.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0PARTNER 3, Evolut and more: TAVR takes the spotlight in 4 late-breaking clinical trials at TCT 2023 - 7 month(s) ago
All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
Is Adding an AI Readout to Mammography Worth It? https://t.co/sUpWKXbj1S #AIRadiology